期刊文献+

三阴性乳腺癌中核因子κB的表达与临床病理及预后的相关性分析 被引量:3

Correlation analysis of the expression of nuclear factor kappa B of triple-negative breast cancer with clinical pathology and prognosis
原文传递
导出
摘要 目的探讨三阴性乳腺癌(TNBC)中核因子κB(NF-κB)的表达与临床病理及预后的关系。方法选择2008年1月至2011年12月间191例乳腺癌患者为研究对象,经本院病理科确诊为TNBC 93例,非TNBC 98例。统计NF-κB表达情况,并对NF-κB表达与年龄、肿瘤分期、淋巴结转移、组织学分级、Ki-67表达、肿瘤大小进行相关性分析。结果 TNBC组NF-κB表达阳性率高于非TNBC组,差异有统计学意义(59.14%vs 43.88%,掊2=4.449 1,P=0.034 9)。NF-κB的表达与年龄、肿瘤分期、肿瘤大小差异无统计学意义,但与TNBC淋巴结转移、组织学分级、Ki-67表达情况差异有统计学意义(均P<0.05)。NF-κB阳性患者预后差于阴性患者,差异有统计学意义(掊2=4.592 3,P=0.032 1);NF-κB表达与3年DFS无明显相关。结论 TNBC中NF-κB的表达阳性率高于非TNBC;NF-κB的表达与TNBC淋巴结转移、组织学分级、Ki-67的表达密切相关;NF-κB阳性表明TNBC预后不良。 Objective To explore the expression, pathology and prognosis of nuclear factor kappa B in triple-negative breast cancer. Methods One hundred and ninty-one breast cancer patients diagnosed by the Department of Pathology from January 2008 to December 2011 were chosen as the research objects, with 93 cases of TNBC and 98 cases of non-TNBC. Statistics was carried out for the correlation analysis of the expression of NF-κB with age, tumor stage, lymph node metastasis, histological grading, Ki-67 expression and tumor size. Results Positive rate of NF-κB expression in TNBC group was higher than the non-TNBC group, and the difference was statistically significant (59.14% vs 43.88%, x^2 = 4.449 1, P = 0.034 9). The expression of NF-κB in TNBC group had no obvious relation to age, tumor stage and tumor size, but it was related to TNBC lymph node metastasis, histological grading, and Ki-67 expression (P 〈 0.05). TNBC patients with negative NF-κB expression had better prognosis than those with positive expression, which was statistically significant (x^2 = 4.592 3, P = 0.032 1). NF-κB expression had no sig- nificant correlation with 3-years DFS. Conclusions The expression of NF-κB in TNBC patients is higher than non-TNBC patients. The expression of NF-κB is closely related to lymph node metastasis, histologi- cal grading and Ki-67 expression. Positive NF-κB expression suggests poorer prognosis for TNBC patients. [Key words] Triple-negative breast cancer; Clinical pathology; Prognosis; Nuclear factor kappa B
出处 《中华普通外科学文献(电子版)》 2015年第1期27-29,44,共4页 Chinese Archives of General Surgery(Electronic Edition)
基金 中山市卫生局科研立项(2013J40) 国家留学基金项目(20071059)
关键词 三阴性乳腺癌 临床病理 预后 核因子ΚB Triple-negative breast cancer Clinical pathology Prognosis Nuclear factor kappa B
  • 相关文献

参考文献8

二级参考文献89

共引文献194

同被引文献17

  • 1WHO. Globocan 2008 : Estimated cancer as global health concern [J].Cancer incidence, mortality prevalence ald disability-adjus- ted life years (DALYs) worldwise in 2008,2nd January 2013 [OL]. http://globocan.iarc.r/(22 February 2013, date last ac- cessed). 被引量:1
  • 2Ossovskaya V, Wang Y, Budoff A, et al. Exploring molecular pathways of triple-negative breast caneer[J]. Genes Cancer, 2011, 2(9): 870-879. 被引量:1
  • 3Baner KR, Brown M, Cress RD, et al. Descoiptive analysis of estrogen receptor (ER) - negative, progesterone receptor (PR) - negative, and HER2 - negative phenotype a population- based study from the California cancer registry[J]. Cancer, 2007, 109 (9) : 1721-1728. 被引量:1
  • 4Tischkowitz M, Brunet JS, B6gin LR, et al. Use of immunohis-tochemical markers can refine prognosis in triple negative breast caneer[J]. BMC Cancer, 2007, 7: 134. 被引量:1
  • 5AJCC癌症分期手册[M].严正,译.广州:中山大学肿瘤防治中心,2010. 被引量:1
  • 6周际昌.实用肿瘤内科治疗学[M].北京:北京科学技术出版社,2012:32. 被引量:1
  • 7马文碉.卡铂联合紫杉醇治疗局部晚期三阴性乳腺癌的Ⅱ期临床研究[D].北京:北京协和医学院,2011. 被引量:1
  • 8Liu Q. Triptolide and its expanding multiple pharmacological {unetions[J]. Int Immunopharmacol, 2011, 11(3): 377-383. 被引量:1
  • 9Wu MB, Wu YL, Zhou J, et al. Structural characteristation of a water-soluble polysaecharide with high branches from the leaves of Taxus chinensis var mairei[J]. Food Chem, 2009, 113:1020-1024. 被引量:1
  • 10张建国,苏永华.华蟾酥毒基药理作用及剂型研究进展[J].浙江中医药大学学报,2009,33(4):608-610. 被引量:8

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部